Efficacy of microbiome-targeted interventions in obesity management- A comprehensive systematic review
Diabetes & Metabolic Syndrome: Clinical Research & Reviews · 2025
DOI: 10.1016/j.dsx.2025.103208 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2025. Verfasst von Dhivya Dhanasekaran und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Ooty, Tamil Nadu, India. Hauptthemen laut MEDLINE: Obesity, Gastrointestinal Microbiome, Probiotics, Fecal Microbiota Transplantation. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Obesity is a global health crisis linked to numerous chronic diseases. The gut microbiome plays a crucial role in human metabolism, and emerging evidence suggests that modulating the microbiome may offer novel therapeutic avenues for obesity management. OBJECTIVE: This systematic review aimed to assess the efficacy and safety of microbiome-targeted interventions, including probiotics, prebiotics, synbiotics, and fecal microbiota transplantation, in improving body composition, metabolic parameters, and inflammatory markers in overweight and obese adults. METHODS: A comprehensive search of PubMed, Scopus, and ScienceDirect was conducted to identify relevant studies published between 2005 and 2023. Included studies were assessed for methodological quality and risk of bias using the Cochrane Collaboration tool. RESULTS: Body composition: Most studies demonstrated significant reductions in body weight, Body mass index, and body fat percentage. METABOLIC PARAMETERS: Improvements were observed in lipid profiles (reduced cholesterol, triglycerides) and glucose metabolism (improved insulin sensitivity). INFLAMMATORY MARKERS: Significant reductions were observed in inflammatory markers such as Interleukins (IL-6, IL-8) and C-reactive protein. MICROBIAL COMPOSITION: Interventions generally led to shifts in microbial composition, with increases in beneficial bacteria such as Bifidobacterium and Lactobacillus. ADVERSE EVENTS: Adverse events were generally minimal and limited. CONCLUSION: This review provides strong evidence that microbiome-targeted interventions can effectively improve body composition, metabolic parameters, and inflammatory markers in individuals with obesity. Further research is needed to optimize intervention strategies, identify specific microbial targets, and translate these findings into effective clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy Practice, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Ooty, Tamil Nadu, India.
- Center for Global Health Research, Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, 602105, Tamil Nadu, India. Electronic address: sarv…
Zitieren
APA
Dhanasekaran, D., Venkatesan, M., & Sabarathinam, S. (2025). Efficacy of microbiome-targeted interventions in obesity management- A comprehensive systematic review. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. https://doi.org/10.1016/j.dsx.2025.103208
Vancouver
Dhanasekaran D, Venkatesan M, Sabarathinam S. Efficacy of microbiome-targeted interventions in obesity management- A comprehensive systematic review. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2025. doi:10.1016/j.dsx.2025.103208
BibTeX
@article{Dhanasekaran2025,
author = {Dhanasekaran, Dhivya and Venkatesan, Manojkumar and Sabarathinam, Sarvesh},
title = {Efficacy of microbiome-targeted interventions in obesity management- A comprehensive systematic review},
journal = {Diabetes & Metabolic Syndrome: Clinical Research & Reviews},
year = {2025},
doi = {10.1016/j.dsx.2025.103208}
}
EUVIMED